Abstract

Abstract To assess effects of a novel rumen-protected folic acid (RPFA) supplement, 180 Angus-cross steers (292 ± 18 kg) were blocked by body weight to pens and randomly assigned to dietary treatments (n = 6 pens/treatment): target intake of 0 (CON), 30 (RPFA-30), 60 (RPFA-60), 90 (RPFA-90), 120 (RPFA-120), or 150 (RPFA-150) mg RPFA·steer-1·d-1. Steers were weighed on d -1, 0, 55, 56 (end of growing), 86, 87, 181, and 182. Liver and blood were collected (two steers/pen) before trial initiation and at the end of growing and finishing. Data were analyzed as a randomized complete block design using ProcMixed of SAS (fixed effects of treatment and block; experimental unit of pen). Liver abscess scores were analyzed using ProcGenmod of SAS. Contrast statements evaluated polynomial effects of RPFA and compared CON vs. RPFA-30. At end of growing, RPFA linearly increased plasma folic acid (P < 0.01) and linearly decreased plasma glucose (P = 0.01). Liver folic acid concentrations at end of growing were greatest for CON, RPFA-90, and RPFA-120 (cubic P = 0.01), and growing period (d 0 to 56) average daily gain and gain:feed were greatest for CON and RPFA-120 (cubic P ≤ 0.03). At end of finishing, RPFA linearly increased plasma folic acid concentrations (P < 0.01), and liver folic acid concentrations were lesser for CON vs. RPFA-30 (P = 0.04). Severe liver abscess percentage tended to be greater for CON vs. RPFA-30 (P = 0.09), while dressing percent was lesser for CON vs. RPFA-30 (P = 0.04). Overall (d 0 to 182) carcass-adjusted gain:feed tended to be greater for CON vs. RPFA-30 (P = 0.09). Although RPFA increased plasma folic acid concentrations throughout the study, feedlot performance was not improved, possibly due to low vitamin B12 status (plasma < 200 pg/mL) of steers, regardless of treatment.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.